Insulinomas are a type of pancreatic neuroendocrine tumor (pNET) that arises from pancreatic endocrine tissue. They are rare, with an estimated incidence of 4 cases per 1 million person-years 7 . While typically larger pNETs are detectable using conventional imaging studies such as transabdominal ultrasound, CT, or MRI, insulinomas are frequently missed by conventional imaging due to their relatively small size. We present the case of a 66-year-old African American male with an insulinoma undetected by contrast-enhanced MRI, that was ultimately localized and diagnosed via endoscopic ultrasound (EUS) with fine needle aspiration (FNA).
CASE PRESENTATIONA 66-year-old African American male with past medical history of hypertension, obstructive sleep apnea, glaucoma, coronary artery disease status post coronary stents, and squamous cell carcinoma of the larynx status post total laryngectomy presented from a rehab facility with weakness, lethargy, and repeated episodes of hypoglycemia. The patient denied history of diabetes, use of oral antihyperglycemic agents, or insulin.On arrival, the patient's glucose level was 35-45 mg/dL on repeated testing; he was started on 10% dextrose (D10) intravenous drip to maintain normoglycemia. Fasting laboratory evaluation (Table 1) was remarkable for elevated levels of insulin, c-peptide, and proinsulin. TSH and ACTH levels were within normal limits. Morning cortisol level at 8am was low at 10.9 mcg/dL; however, cosyntropin stimulation test showed adequate response of cortisol. The patient also had elevated C-reactive protein, low ionized calcium, and a negative insulin autoantibody assay (Table 1).MRI of the abdomen with and without gadolinium contrast and magnetic resonance cholangiopancreatography (MRCP) were performed, demonstrating normal enhancement of the pancreas without masses, a normal pancreatic duct, and no biliary ductal dilatation. Somatostatin-receptor scintigraphy was negative. EUS was performed given continued high clinical suspicion of an insulin-producing tumor, and revealed a 1.2 x 0.8 cm round hypoechoic lesion in the pancreatic head (Figure 1). FNA cytology showed immunohistochemical stains positive for neuroendocrine tumor markers chromogranin and synaptophysin, and a Ki67 proliferation index less than 1%; the stains were negative for insulin. The patient was started on subcutaneous octreotide with ongoing D10 drip.The patient was taken to the operating room; however, resection of the tumor via pancreaticoduodenectomy was aborted secondary to the patient's instability and pressor requirement intraoperatively. Instead, alcohol ablation of the lesion was performed under ultrasound guidance. By post-procedure day 4, the patient was able to maintain normoglycemia off D10 drip and octreotide.